Chemotherapy Induced Peripheral Neuropathy Cipn clinical trials

Explore recruiting chemotherapy induced peripheral neuropathy cipn clinical trials.

Recruiting chemotherapy induced peripheral neuropathy cipn studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chemotherapy Induced Peripheral Neuropathy Cipn trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Capsaicin 179 mg patch versus oral Duloxetine in patients with chemotherapy-induced peripheral neuropathy: a phase 3 randomized multicentric open-label study (CAPNEUCHIM)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Effectiveness and cost-effectiveness of ozone treatment in patients with paresthesia (numbness, tingling) secondary to chemotherapy-induced peripheral neuropathy. Randomized, triple-blind clinical trial (OzoParQT).

Spain

Phase II and Phase III (Integrated) EU CTIS Study details

Chemotherapy Induced Peripheral Neuropathy Cipn trials by city

Chemotherapy Induced Peripheral Neuropathy Cipn in Toronto Chemotherapy Induced Peripheral Neuropathy Cipn in Vancouver Chemotherapy Induced Peripheral Neuropathy Cipn in Montreal Chemotherapy Induced Peripheral Neuropathy Cipn in Calgary Chemotherapy Induced Peripheral Neuropathy Cipn in Edmonton Chemotherapy Induced Peripheral Neuropathy Cipn in Ottawa Chemotherapy Induced Peripheral Neuropathy Cipn in Winnipeg Chemotherapy Induced Peripheral Neuropathy Cipn in Quebec City Chemotherapy Induced Peripheral Neuropathy Cipn in Hamilton Chemotherapy Induced Peripheral Neuropathy Cipn in Kitchener Chemotherapy Induced Peripheral Neuropathy Cipn in London Chemotherapy Induced Peripheral Neuropathy Cipn in Halifax Chemotherapy Induced Peripheral Neuropathy Cipn in New York Chemotherapy Induced Peripheral Neuropathy Cipn in Los Angeles Chemotherapy Induced Peripheral Neuropathy Cipn in Chicago Chemotherapy Induced Peripheral Neuropathy Cipn in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease